Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).
about
Cancer vaccinesCurrent status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines.Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.Immune responses to cancer: are they potential biomarkers of prognosis?Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma.Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
P2860
Q27024438-F442498A-3D79-4210-A17C-D317FC230046Q30412300-2FBB408C-F2E4-48BF-B1ED-48014A33E85AQ36983356-5AB8393F-C64E-493A-9D43-D526AB131E2FQ37414561-D2730139-A1E7-466E-9ACF-B88FCD6A6DDBQ37670779-B571F716-672A-426B-BAEC-80F9F82701F8Q38168904-FF39E45A-B12C-4E45-AAE2-59F38B2860D5Q38764852-EBB04EA4-13DF-443C-9D48-022BFEFD30CDQ39313889-AE80E3D1-DA07-4EBE-94FD-8AA924062814Q39546506-B93D2A79-66B7-44B0-836F-D678DB3B5CF7Q40778413-5F04AD94-3422-4E88-9663-98009F5495CDQ41237376-2D726F09-86E2-4526-B6A8-F79D4627D3D7Q42129387-047A0555-7099-4F8B-92D6-3EFD8C5A9D8DQ58129598-93B6E126-B26C-4142-AC12-1DDEE5D03F1E
P2860
Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Function but not phenotype of ...... ide vaccine trial (ECOG 1696).
@en
type
label
Function but not phenotype of ...... ide vaccine trial (ECOG 1696).
@en
prefLabel
Function but not phenotype of ...... ide vaccine trial (ECOG 1696).
@en
P2093
P2860
P356
P1476
Function but not phenotype of ...... tide vaccine trial (ECOG 1696)
@en
P2093
Carmen Visus
Carsten Schaefer
Grace G Kim
John M Kirkwood
Sandra Lee
Theresa L Whiteside
P2860
P304
P356
10.1002/IJC.26481
P577
2012-01-11T00:00:00Z